Every year, thousands of tonnes of brown algae are extracted from the seabed to obtain compounds such as alginates, a polymer composed of sugars that has high density and strength, offering potential ...

But Youle’s dismissal, along with 10 others at the NIH’s National Institute of Neurological Disorders and Stroke, underscores ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

My wellness journey now is about what makes me feel happy and confident in my own skin, not about my image or what everyone ...

In a groundbreaking scientific achievement, Colossal Biosciences, a biotechnology and genetic engineering company, has ...

During the fourth quarter, the Harbor Health Care ETF returned –10.89%, underperforming the Russell 3000 Growth Health Care ...

The traffic police did not shut the Elphinstone Bridge as previously announced for Thursday but said a decision on its ...

Morgan Stanley lowered the firm’s price target on Alnylam (ALNY) to $268 from $284 and keeps an Equal Weight rating on the shares. The firm is ...

Republican Sen. Todd Young of Indiana speaks with NPR's Steve Inskeep about a range of China issues, from the ...

Recursion Pharmaceuticals (RXRX) shares closed up 27% after the Food and Drug Administration (FDA) said it wants to phase out ...

Republican Sen. Todd Young of Indiana speaks with NPR's Steve Inskeep about a range of China issues, from the administration's trade war with Beijing to China's growing advantage in biotechnology.

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.